BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kaposi Sarcoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
27 results:

  • 1. Exploration in the Mechanism of Ginsenoside Rg5 for the treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
    Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
    Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking.
    Wang Y; Tao X; Gao Y; Jin Z; Guo S; Li Z; Wang M; Zhao R; Zhou W; Wu J
    Medicine (Baltimore); 2023 Jul; 102(29):e34030. PubMed ID: 37478234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
    Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
    BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA damage triggers an interplay between wtp53 and c-Myc affecting lymphoma cell proliferation and kaposi sarcoma herpesvirus replication.
    Arena A; Gilardini Montani MS; Romeo MA; Benedetti R; Gaeta A; Cirone M
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119168. PubMed ID: 34728235
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Successful treatment of HIV-Associated kaposi sarcoma with Immune Checkpoint Blockade.
    Galanina N; Goodman AM; Cohen PR; Frampton GM; Kurzrock R
    Cancer Immunol Res; 2018 Oct; 6(10):1129-1135. PubMed ID: 30194084
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. kaposi's sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    Liu X; Happel C; Ziegelbauer JM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Structural proteins of kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.
    Chudasama P; Konrad A; Jochmann R; Lausen B; Holz P; Naschberger E; Neipel F; Britzen-Laurent N; Stürzl M
    Oncogene; 2015 Jan; 34(5):639-49. PubMed ID: 24469037
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
    Bhatt S; Ashlock BM; Toomey NL; Diaz LA; Mesri EA; Lossos IS; Ramos JC
    J Clin Invest; 2013 Jun; 123(6):2616-28. PubMed ID: 23635777
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of kaposi's sarcoma-associated herpesvirus.
    Li X; Chen S; Sun R
    J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
    Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
    Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Novel regulatory role for kaposi's sarcoma-associated herpesvirus-encoded vFLIP in chemosensitization to bleomycin.
    Masuda Y; Noguchi K; Segawa H; Tanaka N; Katayama K; Mitsuhashi J; Sugimoto Y
    Biochem Biophys Res Commun; 2011 Nov; 415(2):305-12. PubMed ID: 22037577
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].
    Nestle-Krämling C; Bölke E; Budach W; Peiper M; Niederacher D; Janni W; Eisenberger CF; Knoefel WT; Scherer A; Baldus SE; Lammering G; Gerber PA; Matuschek C
    Strahlenther Onkol; 2011 Oct; 187(10):656-64. PubMed ID: 21858416
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and kaposi's sarcoma.
    Roy D; Dittmer DP
    Am J Pathol; 2011 Oct; 179(4):2108-19. PubMed ID: 21819957
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Modulation of drug resistance by artificial transcription factors.
    Blancafort P; Tschan MP; Bergquist S; Guthy D; Brachat A; Sheeter DA; Torbett BE; Erdmann D; Barbas CF
    Mol Cancer Ther; 2008 Mar; 7(3):688-97. PubMed ID: 18319335
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.
    Sarek G; Ojala PM
    Cell Cycle; 2007 Sep; 6(18):2205-9. PubMed ID: 17890905
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeted therapy for kaposi's sarcoma and kaposi's sarcoma-associated herpesvirus.
    Dittmer DP; Krown SE
    Curr Opin Oncol; 2007 Sep; 19(5):452-7. PubMed ID: 17762570
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
    Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
    J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with kaposi's sarcoma-associated herpesvirus.
    Fujimuro M; Inoue H; Teishikata Y; Ishida Y; Yokosawa H
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):635-45. PubMed ID: 16838851
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.